Home > Healthcare > Medical Devices > Therapeutic Devices > Photopheresis Products Market

Photopheresis Products Market Share

Report ID: GMI5958
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Photopheresis Products Market Share

Some of the notable key photopheresis products market players operating in the photopheresis products industry include:

Haemonetics Corporation
Fresenius Kabi
Terumo Corporation
Macopharma
Mallinckrodt Pharmaceuticals
Med Tech Solutions GmbH
Thermo Fisher Scientific
Spectranetics
Therakos

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global market for photopheresis products was valued at over USD 270 million in 2022 and is projected to reach more than USD 440 million by 2032. The growing prevalence of autoimmune diseases is accelerating market growth as these products are primarily used for the treatment of certain blood disorders and immune-mediated conditions.

The closed system segment held a notable revenue share of over USD 150 million in 2022 and will reach more than USD 240 million by 2032, as these closed systems are designed to minimize the risk of contamination during the photopheresis procedure.

The U.S. region accounted for more than USD 95 million in 2022 and will be worth over USD 150 million by 2032, backed by the affordability of photopheresis products among the target population base and ongoing technological developments.

Haemonetics Corporation, Fresenius Kabi, Terumo Corporation, Macopharma, Mallinckrodt Pharmaceuticals, Med Tech Solutions GmbH, Thermo Fisher Scientific, Spectranetics, Therakos, among others.